John B. Bode, Director at ZEVRA THERAPEUTICS, INC. (ZVRA), bought 5,000 shares at $9.17 ($46K) on 2025-08-19, disclosed to the SEC on 2025-08-20.
Open-market purchase of $46k ZVRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ZVRA | BUY | 2023-09-06 | $51K | — | Filing → |
| ZVRA | BUY | 2023-05-19 | $50K | — | Filing → |
| TPUB | BUY | 2014-11-12 | $51K | — | Filing → |